IBT
ERAS icon

International Biotechnology Trust’s Erasca ERAS Stock Holding History

International Biotechnology Trust’s Portfolio ERAS Stock Details ERAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$3.79M Buy
1,926,000
+500,000
+35% +$1.28M 1.28% 23
2023
Q2 		$3.92M Hold
1,426,000
– – 1.19% 26
2023
Q1 		$4.28M Buy
+1,426,000
New +$5.19M 1.19% 30

Other funds holding ERAS

AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

International Biotechnology Trust's ERAS Position: Q3 2023 in Review

International Biotechnology Trust increased its Erasca (ERAS) stake by 35% in Q3 2023, buying an estimated $1.28M and bringing the position to 1,926,000 shares worth $3.79M. The position accounts for 1.28% of the portfolio, ranked #23.

International Biotechnology Trust first reported a position in ERAS in Q1 2023 and has held it in 3 quarters since. The position peaked at $4.28M in Q1 2023. 109 funds tracked by Wall St. Rank hold ERAS as of Q3 2023.

  • International Biotechnology Trust held 1,926,000 shares of Erasca worth $3.79M as of Q3 2023.
  • International Biotechnology Trust bought 500,000 Erasca shares in Q3 2023, an estimated $1.28M.
  • Erasca made up 1.28% of International Biotechnology Trust's portfolio in Q3 2023, its #23 holding.
  • International Biotechnology Trust first reported a position in Erasca in Q1 2023 and has held it in 3 quarters since.
  • International Biotechnology Trust's Erasca position peaked at $4.28M in Q1 2023.
  • 109 funds tracked by Wall St. Rank held Erasca as of Q3 2023.

Based on International Biotechnology Trust's 13F filing for Q3 2023, filed 14 Nov 2023.